genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Genetic Disease Testing
Multiomics Approach Improves Diagnosis of Rare Disease, Methylmalonic Aciduria
Base Editing
Zinc Finger Design AI Tool Opens Door to Large-Scale Gene Therapies
Cancer
Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer
Cancer
Cancer’s Capacity to Resist Treatment Thwarted
Animal Models
Microbiome and its Metabolites Promote Endometriosis in Animal Model
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Bioprocessing
Making Molecules Instead of Growing Them
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Therapeutics
Cardiovascular Drugs
Cardiovascular Drugs
Anti-Ulcerants
Antibacterials
Antibiotics
Anticoagulants
Antidiabetics
Antifungals
Antivirals
Autoimmune Disease Drugs
Biologics
Biosimilars
Cardiovascular Drugs
Cellular Therapeutics
Combination Therapies
Dermatologic Drugs
Enzyme Replacement Therapy
Generics
Hormone Replacement Therapy
Immuno-oncology
Immunotherapies
Lipid Regulators
Mental Health Drugs
Oncologics
Orphan Drugs
Pain
Protein Therapeutics
Psychoactive Drugs
Radiopharmaceuticals
Respiratory Drugs
Traditional Chinese Medications
Vaccines
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Base Editing
FDA Places Clinical Hold on Verve’s Cardio Base Editing Therapy
Genome Editing
Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference
Cardiovascular Drugs
New Heart Disease Therapeutic Target Identified
RNAi
StockWatch: Alnylam Basks in the Glow of Heart Drug’s Phase III Success
Cardiovascular Drugs
HAYA Is Developing Therapeutics Targeting Long Non-Coding RNAs
Cardiovascular Drugs
Cellular Housekeeping Process May Protect against Atherosclerosis
Drug Discovery
Vikram Bajaj, PhD: “Innovation Doesn’t Come from Boston and San Francisco...
Cardiovascular Disease
An App a Day Keeps the Doctor Away: Better Therapeutics Targets...
Cardiovascular Drugs
Merck & Co. to Acquire Acceleron for $11.5B
Cardiovascular Drugs
Pulsing Ultrasound at Kidneys Can Lower Blood Pressure When Medications Don’t
Cardiovascular Drugs
Prescribing the Right Blood Thinner May Pivot on a Genetic Test
Cardiovascular Drugs
Preclinical Study Shows Safety, Efficacy, and Durability of Lowering LDL-Cholesterol Levels...
Cardiovascular Drugs
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
Cardiovascular Drugs
Bayer Approach to Partnerships, Pipelines, and Platforms
Cardiovascular Drugs
Bristol-Myers Squibb to Acquire MyoKardia for $13.1B, Expanding Cardiovascular Franchise
1
2
3
...
6
Page 1 of 6
Scroll Up
Login
Subscribe